Literature DB >> 30311416

Understanding the direct and indirect costs of a first episode of psychosis program: Insights from PAFIP of Cantabria, Spain, during the first year of intervention.

Jacqueline Mayoral-van Son1,2,3,4, María Juncal-Ruiz1,2,3,4, Víctor Ortiz-García de la Foz3, David Cantarero-Prieto5, Carla Blázquez-Fernández5, María Paz-Zulueta6, Paula Paras-Bravo6, José L Ayuso-Mateos4,7, Benedicto Crespo-Facorro2,3,4,8.   

Abstract

AIM: Early intervention psychiatric services for patients with psychosis aim to limit the most damaging outcomes and reduce the patient's risk of social drift, decreasing illness severity and thus containing healthcare costs. There is a scarcity of studies that focus on first-episode psychosis (FEP), and those few that have been published only looked at direct health costs, but not at indirect costs, which make up the bulk of the budget. Our study aims to explore the short-term (1-year follow-up) economic cost of a FEP Program, including both direct and indirect costs.
METHODS: Data were collected retrospectively from the clinical records of 157 patients included in the Programa Atención Fases Iniciales de Psicosis, from Marqués de Valdecilla University Hospital, Santander. Our data collection sheet collated data from direct and indirect costs associated with the illness. Data were also extracted from the Cantabria Health Service Records. STATA 15.0 was used for statistical analysis.
RESULTS: On average, the total costs during the first year were €48 353.51 per patient, with direct healthcare costs being €13 729.47 (28.39%), direct non-medical costs €108.6 (0.22%), and indirect costs €34 515.44 (71.39%). We found that hospitalization costs were higher in males (p = 0.081) and in cannabis users (p = 0.032). The number of relapses increased both, hospitalization and treatment costs (r = 0.40 p = 0.000; r = 0.24 p = 0.067, respectively).
CONCLUSIONS: Intensive Early Intervention in Psychosis Services may result in cost savings by decreasing hospitalization, premature mortality, disability, unemployment, and legal problems; however, the first year after diagnosis would represent the one with the highest costs.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  costs analysis; early intervention services; first episode psychosis; schizophrenia

Mesh:

Year:  2018        PMID: 30311416     DOI: 10.1111/eip.12752

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  3 in total

1.  Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR.

Authors:  Umberto Restelli; Manuel García-Goñi; Michal Lew-Starowicz; Pawel Mierzejewski; Sofia Silvola; Jacqueline Mayoral-van Son; Davide Croce; Paola Rocca; Benedicto Crespo-Facorro
Journal:  Clin Drug Investig       Date:  2020-09       Impact factor: 2.859

2.  Psychosocial interventions for community-dwelling individuals with schizophrenia: study protocol for a systematic review and meta-analysis.

Authors:  Yuki Shikuri; Hiroki Tanoue; Hissei Imai; Hideki Nakamura; Fumitake Yamaguchi; Taichi Goto; Yoshifumi Kido; Aran Tajika; Hirotake Sawada; Yasushi Ishida; Naoki Yoshinaga
Journal:  BMJ Open       Date:  2022-04-29       Impact factor: 3.006

3.  Oral and Palmitate Paliperidone Long-Acting Injectable Formulations' Use in Schizophrenia Spectrum Disorders: A Retrospective Cohort Study from the First Episode Psychosis Intervention Program (CRUPEP).

Authors:  R Segarra; M Recio-Barbero; M Sáenz-Herrero; O Mentxaka; J Cabezas-Garduño; J I Eguíluz; L F Callado
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.